Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Sugimoto

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
International Journal of Hematology|July 9, 2022
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 studyYoko Edahiro, Tomoki Ito, Akihiko Gotoh, et al.
International Journal of Hematology|November 2, 2021
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 studyYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
Ejhaem|July 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential ThrombocythemiaYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
Blood|May 4, 2012
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisAndres Jerez, Yuka Sugimoto, Hideki Makishima, et al.
International Journal of Hematology|October 29, 2024
Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in JapanYuka Sugimoto, Keiki Nagaharu, Eiko Ohya, et al.
Annals of Hematology|July 22, 2024
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysisKeiki Nagaharu, Eiko Ohya, Yoko Edahiro, et al.
International Journal of Hematology|February 20, 2026
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysisKatsuto Takenaka, Tomoki Ito, Norio Komatsu, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
International Journal of Hematology|July 9, 2022
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 studyYoko Edahiro, Tomoki Ito, Akihiko Gotoh, et al.
International Journal of Hematology|November 2, 2021
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 studyYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
Ejhaem|July 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential ThrombocythemiaYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
Blood|May 4, 2012
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisAndres Jerez, Yuka Sugimoto, Hideki Makishima, et al.
International Journal of Hematology|October 29, 2024
Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in JapanYuka Sugimoto, Keiki Nagaharu, Eiko Ohya, et al.
Annals of Hematology|July 22, 2024
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysisKeiki Nagaharu, Eiko Ohya, Yoko Edahiro, et al.
International Journal of Hematology|February 20, 2026
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysisKatsuto Takenaka, Tomoki Ito, Norio Komatsu, et al.
Pageof 8